SquareMind
Latest round
- Series A
Last raised
- Apr 2026
Total raised
- Undisclosed
Investors
- 5
About SquareMind
Based in Paris, France, founded in 2019, SquareMind, SAS, focuses on developing robotic solutions for dermatology. The company was co-founded by Ali Khachlouf (CEO as of 2026) and Tanguy Serrat.\ SquareMind's core offering is the Swan, recognized as the world's first robot designed for full-body dermoscopy. This technology automates skin mapping, facilitating detailed examinations in a matter of minutes. The Swan utilizes advanced artificial intelligence for change detection, improving skin assessment accuracy. Key users include dermatology clinics and healthcare providers in Europe and North America, focused on enhancing access to quality dermatological care. SquareMind generates revenue through direct sales and partnerships centered around the Swan robotic dermoscopy system. The company operates on a B2B model, delivering its technology to dermatology clinics and healthcare facilities via direct sales or leasing agreements, along with service contracts for ongoing maintenance and updates.
Who invested in SquareMind
5 investors across 1 round
See all investors in SquareMind
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 27, 2026
Amount
Undisclosed
Investors
Questions about SquareMind
Who invested in SquareMind?
SquareMind has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SquareMind raised?
SquareMind has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SquareMind last raise money?
SquareMind's most recent round on record is a Series A, in Apr 2026.
What does SquareMind do?
Based in Paris, France, founded in 2019, SquareMind, SAS, focuses on developing robotic solutions for dermatology.
Where is SquareMind headquartered?
SquareMind is headquartered in Paris, France.
Which VCs invest in companies like SquareMind?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back healthcare it companies at SquareMind's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like SquareMind? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.